Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 22, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only change disclosed is a specific share transfer by a director.
Management Commentary and Risks
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this filing. The document is a statutory notification of a share gift transaction.
Key Facts for Investor Verification
- Transaction Type: Transfer by gift of 3,000 Ordinary shares.
- Parties Involved: From Mr. D. Pulman to Mrs. Clare Pulman.
- Date of Transaction: December 22, 2006.
- Regulatory Basis: Notified in accordance with Disclosure Rule 3.1.4R(1)(a).
- Financial Data: None included in this specific filing.